Charge  ||| S:0 E:7 ||| NN
regulation  ||| S:7 E:18 ||| NN
phenomenon  ||| S:18 E:29 ||| NN
predicted  ||| S:29 E:39 ||| VBD
from  ||| S:39 E:44 ||| IN
the  ||| S:44 E:48 ||| DT
modeling  ||| S:48 E:57 ||| NN
of  ||| S:57 E:60 ||| IN
polypeptide  ||| S:60 E:72 ||| JJ
electrophoretic  ||| S:72 E:88 ||| JJ
mobilities  ||| S:88 E:99 ||| NN
as  ||| S:99 E:102 ||| IN
a  ||| S:102 E:104 ||| DT
relevant  ||| S:104 E:113 ||| JJ
mechanism  ||| S:113 E:123 ||| NN
of  ||| S:123 E:126 ||| IN
amyloid-beta  ||| S:126 E:139 ||| FW
peptide  ||| S:139 E:147 ||| FW
oligomerization  ||| S:147 E:163 ||| FW
Electrophoretic  ||| S:163 E:179 ||| FW
mobilities  ||| S:179 E:190 ||| FW
of  ||| S:190 E:193 ||| IN
amyloid-beta  ||| S:193 E:206 ||| NNP
( ||| S:206 E:207 ||| -LRB-
1-40 ||| S:207 E:211 ||| NNP
)  ||| S:211 E:213 ||| -RRB-
and  ||| S:213 E:217 ||| CC
( ||| S:217 E:218 ||| -LRB-
1-42 ||| S:218 E:222 ||| NNP
)  ||| S:222 E:224 ||| -RRB-
peptides  ||| S:224 E:233 ||| NN
and  ||| S:233 E:237 ||| CC
their  ||| S:237 E:243 ||| PRP$
aggregates  ||| S:243 E:254 ||| NNS
are  ||| S:254 E:258 ||| VBP
modeled  ||| S:258 E:266 ||| VBN
to  ||| S:266 E:269 ||| TO
study  ||| S:269 E:275 ||| VB
the  ||| S:275 E:279 ||| DT
amyloidogenic  ||| S:279 E:293 ||| JJ
pathway  ||| S:293 E:301 ||| NNS
associated  ||| S:301 E:312 ||| VBN
with  ||| S:312 E:317 ||| IN
AlzheimerÂ´s  ||| S:317 E:329 ||| NNP
Disease ||| S:329 E:336 ||| NNP
.  ||| S:336 E:338 ||| .
The  ||| S:338 E:342 ||| DT
near  ||| S:342 E:347 ||| JJ
molecule  ||| S:347 E:356 ||| NN
pH  ||| S:356 E:359 ||| NN
generated  ||| S:359 E:369 ||| VBD
by  ||| S:369 E:372 ||| IN
the  ||| S:372 E:376 ||| DT
intraparticle  ||| S:376 E:390 ||| JJ
charge  ||| S:390 E:397 ||| NN
regulation  ||| S:397 E:408 ||| NN
phenomenon  ||| S:408 E:419 ||| NN
during  ||| S:419 E:426 ||| IN
the  ||| S:426 E:430 ||| DT
oligomerization  ||| S:430 E:446 ||| NN
of  ||| S:446 E:449 ||| IN
amyloid-beta  ||| S:449 E:462 ||| NNP
( ||| S:462 E:463 ||| -LRB-
1-40 ||| S:463 E:467 ||| NNP
)  ||| S:467 E:469 ||| -RRB-
and  ||| S:469 E:473 ||| CC
( ||| S:473 E:474 ||| -LRB-
1-42 ||| S:474 E:478 ||| NNP
)  ||| S:478 E:480 ||| -RRB-
peptides  ||| S:480 E:489 ||| NN
is  ||| S:489 E:492 ||| VBZ
evaluated  ||| S:492 E:502 ||| VBN
and  ||| S:502 E:506 ||| CC
discussed  ||| S:506 E:516 ||| VBN
as  ||| S:516 E:519 ||| IN
a  ||| S:519 E:521 ||| DT
relevant  ||| S:521 E:530 ||| JJ
mechanism  ||| S:530 E:540 ||| NN
supporting  ||| S:540 E:551 ||| VBG
the  ||| S:551 E:555 ||| DT
amyloid  ||| S:555 E:563 ||| JJ
cascade  ||| S:563 E:571 ||| NN
hypothesis  ||| S:571 E:582 ||| VBZ
proposed  ||| S:582 E:591 ||| VBN
in  ||| S:591 E:594 ||| IN
the  ||| S:594 E:598 ||| DT
literature ||| S:598 E:608 ||| NN
.  ||| S:608 E:610 ||| .
A  ||| S:610 E:612 ||| DT
theoretical  ||| S:612 E:624 ||| JJ
framework  ||| S:624 E:634 ||| NN
associated  ||| S:634 E:645 ||| VBN
with  ||| S:645 E:650 ||| IN
the  ||| S:650 E:654 ||| DT
oligomerization  ||| S:654 E:670 ||| NN
of  ||| S:670 E:673 ||| IN
amyloid-beta  ||| S:673 E:686 ||| JJ
peptides  ||| S:686 E:695 ||| NNS
including  ||| S:695 E:705 ||| VBG
simple  ||| S:705 E:712 ||| JJ
scaling  ||| S:712 E:720 ||| NN
laws  ||| S:720 E:725 ||| NNS
and  ||| S:725 E:729 ||| CC
the  ||| S:729 E:733 ||| DT
consideration  ||| S:733 E:747 ||| NN
of  ||| S:747 E:750 ||| IN
electrokinetic  ||| S:750 E:765 ||| NN
and  ||| S:765 E:769 ||| CC
hydrodynamic  ||| S:769 E:782 ||| JJ
global  ||| S:782 E:789 ||| JJ
properties  ||| S:789 E:800 ||| NNS
of  ||| S:800 E:803 ||| IN
oligomers  ||| S:803 E:813 ||| NN
is  ||| S:813 E:816 ||| VBZ
presented ||| S:816 E:825 ||| VBN
.  ||| S:825 E:827 ||| .
The  ||| S:827 E:831 ||| DT
central  ||| S:831 E:839 ||| JJ
finding  ||| S:839 E:847 ||| NN
is  ||| S:847 E:850 ||| VBZ
the  ||| S:850 E:854 ||| DT
explanation  ||| S:854 E:866 ||| NN
of  ||| S:866 E:869 ||| IN
the  ||| S:869 E:873 ||| DT
near  ||| S:873 E:878 ||| JJ
molecule  ||| S:878 E:887 ||| NN
pH  ||| S:887 E:890 ||| JJ
change  ||| S:890 E:897 ||| NN
toward  ||| S:897 E:904 ||| IN
the  ||| S:904 E:908 ||| DT
pI  ||| S:908 E:911 ||| JJ
when  ||| S:911 E:916 ||| WRB
the  ||| S:916 E:920 ||| DT
oligomerization  ||| S:920 E:936 ||| JJ
number  ||| S:936 E:943 ||| NN
increases ||| S:943 E:952 ||| NNS
.  ||| S:952 E:954 ||| .
These  ||| S:954 E:960 ||| DT
results  ||| S:960 E:968 ||| NNS
allow  ||| S:968 E:974 ||| VBP
one  ||| S:974 E:978 ||| CD
to  ||| S:978 E:981 ||| TO
rationalize  ||| S:981 E:993 ||| VB
consecutive  ||| S:993 E:1005 ||| JJ
physical  ||| S:1005 E:1014 ||| JJ
stages  ||| S:1014 E:1021 ||| NNS
that  ||| S:1021 E:1026 ||| WDT
validate  ||| S:1026 E:1035 ||| VBZ
the  ||| S:1035 E:1039 ||| DT
amyloid  ||| S:1039 E:1047 ||| JJ
cascade  ||| S:1047 E:1055 ||| NN
hypothesis ||| S:1055 E:1065 ||| NN
.  ||| S:1065 E:1067 ||| .
Concluding  ||| S:1067 E:1078 ||| VBG
remarks  ||| S:1078 E:1086 ||| NNS
involving  ||| S:1086 E:1096 ||| VBG
mainly  ||| S:1096 E:1103 ||| RB
the  ||| S:1103 E:1107 ||| DT
effects  ||| S:1107 E:1115 ||| NNS
of  ||| S:1115 E:1118 ||| IN
pair  ||| S:1118 E:1123 ||| NN
and  ||| S:1123 E:1127 ||| CC
intraparticle  ||| S:1127 E:1141 ||| JJ
charge  ||| S:1141 E:1148 ||| NN
regulation  ||| S:1148 E:1159 ||| NN
phenomena  ||| S:1159 E:1169 ||| NNS
on  ||| S:1169 E:1172 ||| IN
the  ||| S:1172 E:1176 ||| DT
amyloidogenic  ||| S:1176 E:1190 ||| JJ
pathway  ||| S:1190 E:1198 ||| NN
with  ||| S:1198 E:1203 ||| IN
some  ||| S:1203 E:1208 ||| DT
suggestions  ||| S:1208 E:1220 ||| NNS
for  ||| S:1220 E:1224 ||| IN
future  ||| S:1224 E:1231 ||| JJ
research  ||| S:1231 E:1240 ||| NN
are  ||| S:1240 E:1244 ||| VBP
provided ||| S:1244 E:1252 ||| VBN
.  ||| S:1252 E:1254 ||| .
